Stay updated on Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page, replacing the expected study record content. This blocks access to the trial details and related navigation.
    Difference
    17%
    Check dated 2026-09-19T22:21:05.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Adds the NIH grant/contract year 2016 and updates the document revision to v3.6.6 in the study record.
    Difference
    0.0%
    Check dated 2026-08-29T18:35:46.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    A new 'Revision: v3.6.5' label was added; the 'Plain Language Summary' section was removed, and the prior 'Revision: v3.6.4' reference was removed.
    Difference
    0.0%
    Check dated 2026-08-08T09:37:37.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page’s revision has been updated from v3.6.3 to v3.6.4, indicating a minor metadata update to the page. This does not correspond to changes in study information or functionality but reflects an updated documentation version.
    Difference
    0.0%
    Check dated 2026-07-25T01:03:13.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    Page revision updated to v3.6.3, signaling a new build of the page. This change does not modify the study details or other user-facing content.
    Difference
    0.0%
    Check dated 2026-07-03T13:34:45.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.0 to v3.6.2, indicating a version update. This change updates metadata without altering study information or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-06-26T10:25:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.